Dr Praveen Thokala MASc, PhD
HEDS, ScHARR
The University of Sheffield
Regent Court
30 Regent Street
Sheffield
S1 4DA
UK
Office:
Tel: (+44) (0)114 222 0784
Fax: (+44) (0)114 272 4095
E-mail: p.thokala@sheffield.ac.uk
Biography
I joined HEDS in March 2010 after completing a MASc from the University of Toronto and a PhD from the University of Southampton. During my time at ScHARR I have worked on several health economic modelling projects, including health technology assessment (HTA) of diagnostic strategies for suspected acute coronary syndrome (ACS) and telemonitoring for heart failure.
I have also worked with the NICE Decision Support Unit (DSU) in assessing the applicability of multi criteria decision analysis (MCDA) in health technology assessment (HTA) and I was also involved in the DSU assessment of the economic model submitted by the manufacturer of donepezil for the treatment of Alzheimer's disease.
Research interests
My research interests are:
- Healthcare modelling
- Health economics
- Multi-criteria decision analysis
- Optimisation
Teaching interests
I co-supervise three PhD students and I am co-module leader for the HAR671 - OR Techniques in Health Resource Allocation on the MSc in Health Economic and Decision Modelling. I am also involved in the organisation of HEDS and ScHARR seminar series.
Professional activities
- PhD student experience officer for ScHARR
- Member of SMDM, ISPOR and Operational Research Society
- Reviewer for the Value in Health Journal
Current projects
I am currently working on the following projects:
- Modelling generic type-1 diabetes model to estimate the cost-effectiveness of Dose Adjustment for Normal Eating (DAFNE) and other interventions
- Cost-effectiveness modelling of cardiac magnetic resonance (CMR) compared with current existing testing pathways in ischaemic cardiomyopathy
- Overcoming barriers to Mainstreaming Assisted Living Technologies (MALT), Technology Strategy Board Assisted Living Innovation Platform (with ESRC and NIHR)
Key publications
- Thokala, P. "Multiple Critieria Decision Analysis for Health Technology Assessment." Report for NICE Decision Support Unit, 2011
- Bond et al. "The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of TA111): a systematic review and economic model. Health Technology Assessment, 2012;16(21)
- P Thokala, J Scanlan and A Chipperfield. "A framework for aircraft cost optimisation using multidisciplinary analysis" Journal of Aircraft (in press)